| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Pacific Pulmonary Services is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Novato, CA. To find more information about Pacific Pulmonary Services, please visit www.ppsc.com
Trinity Health is a nonprofit, integrated care system serving northwest/central North Dakota and Eastern Montana. With a tertiary care hospital in Minot, close to a dozen rural health clinics, and a long-term care facility, Trinity provides a full complement of healthcare services to the region.
Royal Life Centers is an addiction treatment network with top-rated drug and alcohol detox and rehab centers. Our inpatient and outpatient programs are multi-accredited.
Luna NanoWorks is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Danville, VA. To find more information about Luna NanoWorks, please visit www.lunananoworks.com